ArticleBMC cardiovascular disorders2025
Trends and sociodemographic disparities in the circulatory disease prevalence in the United States: An analysis of the National Health Interview Survey database (2019-2022).
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCirculatory diseases are a leading cause of mortality in the United States (U.S). This study examined trends and disparities in the prevalence of angina pectoris (AP), coronary heart disease (CHD), myocardial infarction (MI), and hypertension (HTN) among U.S. adults from 2019 to 2022. MATERIALS AND
methodsThe National Health Interview Survey (NHIS) database from the Centers for Disease Control and Prevention (CDC) was analyzed using Joinpoint regression analysis to determine annual percentage changes (APCs) and prevalence percentages with 95% confidence intervals. The data was stratified by year, gender, age, race, veteran status, social vulnerability index (SVI), employment status, nativity, census region, and metropolitan statistical area (MSA) status.
resultsPatients aged 75 and older had the highest incidence rates of all circulatory diseases. HTN was most prevalent, remaining stable at around 27% from 2019 to 2022. Males had a higher prevalence than females, remaining stable overall. CHD rates increased from 4.6% in 2019 to 4.9% in 2020, with males again showing higher rates and both genders showing significant increases over time. White individuals had the highest CHD incidence (5.4% in 2022), with the West having the lowest (3.8% in 2022). AP prevalence was stable but higher in males throughout the study period with insignificant changes in either gender. MI prevalence remained stable from 3.1% in 2019 to 3.0% in 2022, with White individuals and the South region demonstrating the highest MI prevalence (3.3% in 2022 for both) respectively.
conclusionThe rising prevalence of certain circulatory diseases requires immediate intervention. Targeted actions should prioritize high-risk groups, including males, older adults, veterans, and the unemployed, to reduce the burden of these diseases and improve cardiovascular health among U.S. adults.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.